Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Renal Cell

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Recruiting

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

NCT07128680

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +20 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Medical Center Irvine, California, United States

View Trial Details

Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

NCT07049926

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: UCSF Medical Center at Mission Bay ( Site 5008) San Francisco, California, United States

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026) Mineola, New York, United States

Laura and Isaac Perlmutter Cancer Center ( Site 5016) New York, United States

Memorial Sloan Kettering Cancer Center ( Site 5002) New York, United States

View all 30 locations

View Trial Details

Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

NCT02830724

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +41 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View all 13 locations

View Trial Details

Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

NCT07297667

Conditions: Adenocarcinoma, Alveolar Soft Part Sarcoma, Breast Diseases, +25 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

University Health Network Toronto, Ontario, Canada

View Trial Details

Recruiting

Registry Platform Urologic Cancer

NCT03374267

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Multiple sites, Germany Multiple Locations, Germany

View Trial Details

Recruiting

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

NCT07564232

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Recruiting

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

NCT07028125

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations: Centre Hospitalier d'Annecy Annecy, France

Institut Sainte Catherine Avignon, France

Centre Hospitalier de Bayeux Bayeux, France

CH Boulogne sur Mer Boulogne-sur-Mer, France

View all 19 locations

View Trial Details

Recruiting

R.E.C.K vs Exparel in Robotic Nephrectomy

NCT07092566

Conditions: Adenocarcinoma, Agnosia, Carcinoma, +23 more
Locations: Levine Cancer Charlotte, North Carolina, United States

View Trial Details

Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

NCT03972657

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Mayo Clinic Phoenix, Arizona, United States

University of Arizona Tucson, Arizona, United States

John Wayne Cancer Institute (JWCI) Santa Monica, California, United States

View all 24 locations

View Trial Details